Skip to content

Caleigh Propes

5 papers in the library · 20 citations · publishing 2024-2026

Papers

Sort Most recent Most cited

Balancing safety and access in Oregon’s psilocybin services

International Journal of Drug Policy June 13, 2026 Katherine Cheung, Caleigh Propes, David B. Yaden

As jurisdictions across the U.S. consider enacting policies that facilitate access to psychedelics, they must determine how the desire to expand access to these substances should be weighed against the need to adequately protect safety. Oregon's psilocybin services program offers an important early case study of this balance in practice. Under the Psilocybin Services Act, adults over 21 are...

Gaps in US Psychedelic Policy and How to Close Them

JAMA Health Forum November 7, 2025 Caleigh Propes, Katherine Cheung, Matthew D. Eisenberg et al. 4 citations

This Viewpoint discusses how to fill policy gaps surrounding the use of psychedelics to treat mental health and substance use conditions, should they be approved by the US Food and Drug Administration.

Informed Consent Documents from Psychedelic Clinical Trials: A Descriptive Ethical Analysis.

AJOB empirical bioethics July 16, 2025 Katherine Cheung, Caleigh Propes, Marianna Graziosi et al. 4 citations

Classic psychedelics, such as psilocybin and LSD, evoke certain kinds of altered states of consciousness. Specific features of the experience, such as its allegedly ineffable nature, have been discussed as posing challenges to the informed consent process. A growing call for tailored informed consent documents (ICDs) in the psychedelic bioethics literature raises the question of how closely...

Psychedelic group-based integration: ethical assessment and initial recommendations

International Review of Psychiatry June 5, 2024 Katherine Cheung, Caleigh Propes, Edward Jacobs et al. 11 citations

A number of organizations have developed or are developing psychedelic integration groups, held in person or online. In parallel, there have been calls to make enhanced integration available in the community after clinical trials. Here, we explore a potential reason why individuals may seek out these groups: namely, the feelings of disconnection and loneliness that may arise after the...